Medical News

RSS
Study: Repeat sternotomy for surgical aortic valve replacement safe for octogenarian patients

Study: Repeat sternotomy for surgical aortic valve replacement safe for octogenarian patients

Researchers describe benefits of establishing Center for Professional and Peer Support at BWH

Researchers describe benefits of establishing Center for Professional and Peer Support at BWH

Genetic variations influence risk for developing choline deficiency symptoms

Genetic variations influence risk for developing choline deficiency symptoms

ATHENA develops surrogate organ system for toxicity testing

ATHENA develops surrogate organ system for toxicity testing

Research roundup: Distance from a transplant center; Medicaid prenatal care; metastasis of email; profiting from Medicare Advantage

Research roundup: Distance from a transplant center; Medicaid prenatal care; metastasis of email; profiting from Medicare Advantage

Certain inherited DNA sequences may affect prognosis of bladder cancer patients

Certain inherited DNA sequences may affect prognosis of bladder cancer patients

Toshiba launches CardioLine software for faster and more accurate MR cardiac exams

Toshiba launches CardioLine software for faster and more accurate MR cardiac exams

Aeterna Zentaris declares effectiveness of Form F-3 shelf registration statement filed with SEC

Aeterna Zentaris declares effectiveness of Form F-3 shelf registration statement filed with SEC

Gastric surgery reduces heart attack risk in obese people

Gastric surgery reduces heart attack risk in obese people

Dental associations promote National Facial Protection Month, raise awareness on sports-related injuries

Dental associations promote National Facial Protection Month, raise awareness on sports-related injuries

Viewpoints: Nothing 'magical' about 6 million enrollees; the high cost of hep C medicine

Viewpoints: Nothing 'magical' about 6 million enrollees; the high cost of hep C medicine

RXi Pharmaceuticals provides business update, reports Q4 and full year 2013 financial results

RXi Pharmaceuticals provides business update, reports Q4 and full year 2013 financial results

Nephros’ total revenues decrease $67,000 to 4% in the year ended December 31, 2012

Nephros’ total revenues decrease $67,000 to 4% in the year ended December 31, 2012

Nautilus offers second-look financing to Genesis Credit

Nautilus offers second-look financing to Genesis Credit

Antibe Therapeutics increases previously announced non-brokered private placement to up to $5,000,000

Antibe Therapeutics increases previously announced non-brokered private placement to up to $5,000,000

New research reports on China Dental Care market and China mask industry

New research reports on China Dental Care market and China mask industry

Stigmatization may do more harm than good for modern humans, say researchers

Stigmatization may do more harm than good for modern humans, say researchers

Roundup: Texas Medicaid fraud settlement; Texas abortion law upheld; Va. mental health tragedy details

Roundup: Texas Medicaid fraud settlement; Texas abortion law upheld; Va. mental health tragedy details

RegeneRx obtains $1.35M payment pursuant to product license, securities purchase deal with G-treeBNT

RegeneRx obtains $1.35M payment pursuant to product license, securities purchase deal with G-treeBNT

Nordion enters into definitive agreement to be acquired by Sterigenics

Nordion enters into definitive agreement to be acquired by Sterigenics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.